Viewing Study NCT07213804


Ignite Creation Date: 2025-12-24 @ 9:06 PM
Ignite Modification Date: 2025-12-25 @ 6:57 PM
Study NCT ID: NCT07213804
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2025-10-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Two-Part Phase 3 Study of LY4170156 in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module